A Coach-Guided Online Acceptance and Commitment Therapy (ACT) Intervention for Stroke Survivors
NCT ID: NCT05097040
Last Updated: 2022-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2022-01-09
2022-02-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ACT-group for Stroke Survivors (Pilot Study)
NCT06282029
Wellbeing After Stroke (WAterS): Supporting Adjustment and Wellbeing After Stroke
NCT04655937
Adapting Acceptance and Commitment Therapy for Stroke Survivors With Aphasia
NCT04984239
Mindfulness After Stroke
NCT04553679
Effectiveness of Mindfulness After a Stroke
NCT05029193
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acceptance and commitment therapy (ACT) group
A total of 7 ACT sessions individually guided by a trained coach through Zoom videoconferencing
acceptance and commitment therapy (ACT)
The intervention group will receive individual ACT sessions guided by a trained coach for one hour per week over 6 weeks through Zoom videoconferencing. Also, a one-time 1-hour booster session will be provided at 1-month follow-up to facilitate the maintenance of treatment effects.
Control group
Care as usual
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acceptance and commitment therapy (ACT)
The intervention group will receive individual ACT sessions guided by a trained coach for one hour per week over 6 weeks through Zoom videoconferencing. Also, a one-time 1-hour booster session will be provided at 1-month follow-up to facilitate the maintenance of treatment effects.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having at least mild symptoms of psychological distress measured by the Depression, Anxiety and Stress Scale
* having a computer or a smartphone with internet access at home
* being able to provide informed consent by understanding the nature of study participation
Exclusion Criteria
* a diagnosis of severe cognitive impairment (e.g., dementia)
* inability to understand spoken and/or written English
* having severe communication difficulties (e.g., aphasia and dysarthria) that can impede study participation
* having a life-threatening illness (e.g. advanced cancer or advanced heart failure) that would make survival for 6 months unlikely
* having a diagnosis of other central nervous system disorders other than stroke or a severe mental illness (e.g., psychosis)
* currently receiving a psychological therapy or participating in another study that may affect mental health
* having a prior experience in ACT
* having psychiatric hospitalizations or diagnoses of mental illness in the previous two years
* taking antipsychotic medication at the time of recruitment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Areum Han
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Areum Han, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-300008160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.